Clinical Trials
Uveitis
Active Studies
SANDCAT (Genentech Roche)
A Phase 3, Multicenter, Randomized, Double-masked, Sham-controlled Study To Investigate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of RO7200220 Administered Intravitreally In Patients With Uveitic Macular Edema.
Completed Studies
AZALEA (Clearside Biomedical)
A Phase 3, Open-label Safety Study Of Suprachoroidal Triamcinolone Acetonide Injectable Suspension In Patients With Non-infectious Uveitis.
DOGWOOD (Clearside)
A Phase 2, 6 Month, Randomized, Masked, Multicenter Study To Assess The Safety And Efficacy Of CLS-TA, Triamcinolone Acetonide Injectable Suspension In The Treatment Of Subjects With Macular Edema Following Uveitis.
LUMINA 010906IN (Santen)
A Phase 3, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ìg DE-109 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye.
LX211-11 (LUX BIOSCIENCE)
Phase 3 Study Of The Efficacy And Safety Of Voclosporin For Non-infectious Uveitis.
MAGNOLIA (Clearside Biomedical)
A Multicenter, Non-interventional Extension Study Of The Safety And Efficacy Of CLS-TA For The Treatment Of Macular Edema Associated With Non-infectious Uveitis.
PEACHTREE (Clearside Biomedical)
A 6 Month, Phase 3, Randomized, Masked, Controlled Clinical Trial To Study The Safety And Efficacy And Safety Of Triamcinolone Acetonide Injectable Suspension (CLS-TA) For The Treatment Of Subjects With Macular Edema Associated With Non-infectious Uveitis.
SAKURA (SANTEN)
A 2 Year Phase 3 Active Treatment Controlled Study Assessing The Efficacy And Safety Of Sirolimus For The Treatment Of Non-infectious Uveitis.
TAHOE (NCRVA and Allergan)
A 6 Month Prospective Study Of The Dexamethasone Intravitreal Implant (Ozurdex) For Uveitic Macular Edema.
VITRASERT
The Use Of A Sustained-release Ganciclovir Implant To Treat Cytomegalovirus Retinitis.
